Improved long-term biocompatibility of coronary stents by plasma coating process

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$1,355,581.00
Award Year:
2012
Program:
SBIR
Phase:
Phase II
Contract:
4R44HL097485-02
Award Id:
n/a
Agency Tracking Number:
R44HL097485
Solicitation Year:
2012
Solicitation Topic Code:
NHLBI
Solicitation Number:
PA10-050
Small Business Information
1005 BROOK TROUT CT, COLUMBIA, MO, -
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
800407343
Principal Investigator:
MENG CHEN
(573) 234-6451
chenmeng@nanovamed.com
Business Contact:
HAO LI
(573) 884-5510
lihao@nanovamed.com
Research Institute:
Stub




Abstract
DESCRIPTION (provided by applicant): Improved long-term biocompatibility of coronary stents by plasma coating process Abstract Drug-eluting stents (DES) have been widely used to treat patients of cardiac disease due to their better ability to control restenosis than bare metal stents (BMS). However, a serious adverse outcome of late stent thrombosis in patients treated with DES has been reported, which leads to fatal heart attack and death even though it occurs at low rate. Thus, for safe and effective clinical use, a coronary stent needs to have better biocompatibility on its surface that will provide sufficient thrombo-resistance in addition to inhibiting cell proliferation thereby slowing down healing of tissues around the stent. Nanova, Inc. is developing a novel coating layer of high thrombo-resistance on the surface of metallic biomaterials of which coronary stents are made. An environmentally benign technology, low temperature plasma process is used to deposit an ultra-thin (nano-scale) but continuouslayer of coating, sufficient to generate desired abrasion resistance and immobilize the bioactive functional groups created in the subsequent plasma surface treatment to prevent blood clots and restenosis, but thin enough to allow for stent expansion without cracking when delivered into patients. The knowledge gained in this innovative research project will also benefit research and development for improved biocompatibility in other implantable medical devices such as pacemakers, pulse generators, cardiac defibrillators and bio-sensors.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government